glp-1 data Prescriptions Quadruple Since 2021 Alongside Decline In Obesity What Early Clinical Data Is

Advancing public health priorities together Know Your Numbers is funded through the 20252026 Community Health Improvement Plan (CHIP) Partnership Grant awarded by Cobb & Douglas Public Health

Supplement patches operate in an entirely different regulatory and scientific category

This gradual escalation allows the body to adapt to the medication's effects

Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge

Key Safety Findings: 12.3% placebo-adjusted weight loss at 28 weeks Discontinuation rate: ~10% (predominantly GI-related) Adverse events: Mild-moderate nausea and diarrhea (consistent with GLP-1 class) Zero severe diarrhea cases reported No new safety signals vs